Description
Canalia DR 30 mg is a delayed-release capsule containing Dexlansoprazole 30 mg, a proton pump inhibitor (PPI) formulated by Aristopharma Ltd. It works by reducing the production of gastric acid, offering effective relief from acid-related gastrointestinal conditions. The dual delayed-release technology provides extended acid suppression, ensuring sustained symptom control throughout the day.
.webp)
 1000 MG.jpg)
.jpeg)
 4ML.jpg)
.jpeg)
.webp)
.webp)
Change Language